Modulation of Central Hypersensitivity in Chronic Musculoskeletal Pain by Intravenous Tropisetron
NCT00889499
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Pain
Chronic Disease
Interventions
DRUG:
Tropisetron 2 mg
DRUG:
Tropisetron 5mg
DRUG:
Placebo
Sponsor
Insel Gruppe AG, University Hospital Bern